Journal
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES
Volume 26, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jctube.2022.100296
Keywords
Cardiovascular device infection; Rapidly growing mycobacteria; Left ventricular assist device; Case series
Categories
Ask authors/readers for more resources
Cardiovascular device infection due to rapidly growing mycobacteria (RGM) is becoming increasingly important. We report seven cases of RGM cardiovascular device infection and found that all patients had comorbidities, resulting in different treatment approaches.
Cardiovascular device infection due to rapidly growing mycobacteria (RGM) is rarely encountered in clinical practice. Due to the increasing number of indications and use of cardiovascular devices in an aging population, optimized management of these infections is of great importance. We report seven cases of RGM cardiovascular device infection. Three patients had left-ventricular assist device (LVAD) infections; two patients had cardiovascular implantable device (CIED) infections; and one had an aortic vascular stent infection. Specific cardiac valvular infection was not detected among any of the patients. All patients had a high number of comorbidities which limited some patients from receiving optimal combination antimicrobial therapy. The prognosis of cardiovascular device infections with RGM is guarded with only four patients still alive; however, the treatment approach for each patient varied considerably and often based on concurrent medical conditions, overall adjustments to goals of care, and specific patient preferences. Further analysis of cardiovascular device infections with RGM is warranted to establish a more systematic approach in successful management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available